In AML, recurrent chromosomal rearrangements fuse KAT6A to transcriptional coactivators, including P300 (EP300), CBP (CREBBP), and nuclear receptor coactivators (NCOA3 and TIF2). Here, KAT6A is linked to acute myeloid leukemia.